Royal Bank Of Canada Bellerophon Therapeutics, Inc. Transaction History

Royal Bank Of Canada

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	BUY	$0.68 - $12.39 $122 - $2,230	180 Added 1500.0%	192 $0
Q1 2023 May 15, 2023	SELL	$0.9 - $7.89 $60 - $528	-67 Reduced 84.81%	12 $0
Q4 2022 Feb 14, 2023	SELL	$0.67 - $1.2 $116 - $208	-174 Reduced 68.77%	79 $0
Q2 2022 Aug 15, 2022	SELL	$0.85 - $2.36 $1 - $4	-2 Reduced 0.78%	253 $0
Q1 2022 May 16, 2022	SELL	$1.82 - $3.24 $3,956 - $7,043	-2,174 Reduced 89.5%	255 $1,000

Q4 2021 Feb 14, 2022	BUY	$2.36 - $4.05 $5,321 - $9,132	2,255 Added 1295.98%	2,429 $7,000
Q3 2021 Nov 15, 2021	SELL	$3.75 - $4.86 $2,658 - $3,445	-709 Reduced 80.29%	174 $1,000
Q2 2021 Aug 16, 2021	BUY	$3.83 - $5.65 $3,381 - $4,988	883 New	883 $4,000

44K

Ticker BLPH
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 9,545,450
Market Cap $477K
Description
Bellerophon Therapeutics, Inc., a clinical-stage therapeutics company, focuses on the development of products for the treatment of cardiopulmonary diseases in the United States. Its product includes INOpulse, a proprietary pulsatile nitric oxide delivery platform for the treatment of pulmonary hypertension. The company engages in the development...

Get notified when there are updates to the investment portfolio of Royal Bank Of Canada, based on Form 13F filings with the SEC.

Stay updated on Royal Bank Of Canada with notifications on news.